Financials

News Ideas Technicals Forecast

KALV fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of KalVista Pharmaceuticals, Inc.

Total assets of KALV for Q3 23 is 113.97 M USD, 17.86% less than the previous Q2 23. And total liabilities increased by 4.48% in Q3 23 to 25.39 M USD.

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—